Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01159860|
Recruitment Status : Unknown
Verified June 2010 by Lance Wood, Milton S. Hershey Medical Center.
Recruitment status was: Active, not recruiting
First Posted : July 12, 2010
Last Update Posted : August 25, 2011
Seborrheic keratoses (SK's) are very common, but harmless skin lesions that commonly appear during adult life. Patients with seborrheic keratoses frequently desire treatment due to symptoms of itching and irritation or for cosmetic purposes. Seborrheic keratoses can be easily removed and have been treated in a number of different ways. Two of the simplest and most successful ways to remove seborrheic keratoses are cryosurgery and curettage.
The investigators are conducting this study to see which of these two treatments has the best result.
Approximately 24-30 people will take part in this research study at the Hershey Medical Center.
|Condition or disease||Intervention/treatment|
|Seborrheic Keratosis||Procedure: cryosurgery Procedure: Curettage|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?|
|Study Start Date :||July 2010|
|Estimated Primary Completion Date :||October 2011|
|Estimated Study Completion Date :||October 2011|
Active Comparator: Cryosurgery
One lesion on the patients' trunk or proximal extremities will be treated with cryosurgery.
freezing of lesion with liquid nitrogen
Active Comparator: Curettage
One lesion on one side of the patients' trunk or proximal extremities will be treated by curettage.
the lesion will be anesthetized and destroyed with a curette.
- Partial or complete resolution of treated lesion. [ Time Frame: 6 weeks ]Follow up evaluation by a blinded physician along with the gathering of patient information via questionnaires will be obtained at the completion of the study.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01159860
|United States, Pennsylvania|
|Penn State Milton S. Hershey Medical Center|
|Hershey, Pennsylvania, United States, 17033|
|Principal Investigator:||Lance D. Wood, M.D.||Milton S. Hershey Medical Center|